Literature DB >> 18925637

Tau isoform regulation is region- and cell-specific in mouse brain.

Pamela McMillan1, Elena Korvatska, Parvoneh Poorkaj, Zana Evstafjeva, Linda Robinson, Lynne Greenup, James Leverenz, Gerard D Schellenberg, Ian D'Souza.   

Abstract

Tau is a microtubule-associated protein implicated in neurodegenerative tauopathies. Alternative splicing of the tau gene (MAPT) generates six tau isoforms, distinguishable by the exclusion or inclusion of a repeat region of exon 10, which are referred to as 3-repeat (3R) and 4-repeat (4R) tau, respectively. We developed transgenic mouse models that express the entire human MAPT gene in the presence and absence of the mouse Mapt gene and compared the expression and regulation of mouse and human tau isoforms during development and in the young adult. We found differences between mouse and human tau in the regulation of exon 10 inclusion. Despite these differences, the isoform splicing pattern seen in normal human brain is replicated in our mouse models. In addition, we found that all tau, both in the neonate and young adult, is phosphorylated. We also examined the normal anatomic distribution of mouse and human tau isoforms in mouse brain. We observed developmental and species-specific variations in the expression of 3R- and 4R-tau within the frontal cortex and hippocampus. In addition, there were differences in the cellular distribution of the isoforms. Mice transgenic for the human MAPT gene exhibited higher levels of neuronal cell body expression of tau compared to wildtype mice. This neuronal cell body expression of tau was limited to the 3R isoform, whereas expression of 4R-tau was more "synaptic like," with granular staining of neuropil rather than in neuronal cell bodies. These developmental and species-specific differences in the regulation and distribution of tau isoforms may be important to the understanding of normal and pathologic tau isoform expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925637      PMCID: PMC2845852          DOI: 10.1002/cne.21867

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  86 in total

1.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 2.  Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.

Authors:  Stuart C Feinstein; Leslie Wilson
Journal:  Biochim Biophys Acta       Date:  2005-01-03

3.  Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.

Authors:  Michael H Donovan; Umar Yazdani; Rebekah D Norris; Dora Games; Dwight C German; Amelia J Eisch
Journal:  J Comp Neurol       Date:  2006-03-01       Impact factor: 3.215

4.  Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.

Authors:  Mark S Forman; Devika Lal; Bin Zhang; Deepa V Dabir; Eric Swanson; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

5.  The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

Authors:  A J Myers; M Kaleem; L Marlowe; A M Pittman; A J Lees; H C Fung; J Duckworth; D Leung; A Gibson; C M Morris; R de Silva; J Hardy
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

6.  Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.

Authors:  Victoria Zhukareva; Sonali Joyce; Teresa Schuck; Vivianna Van Deerlin; Howard Hurtig; Roger Albin; Sid Gilman; Steven Chin; Bruce Miller; John Q Trojanowski; Virginia M-Y Lee
Journal:  Ann Neurol       Date:  2006-09       Impact factor: 10.422

7.  Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.

Authors:  Yasuhiro Fujino; Deng-Shun Wang; Natalie Thomas; Marisol Espinoza; Peter Davies; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2005-03       Impact factor: 3.685

8.  High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

Authors:  Rosa Rademakers; Stacey Melquist; Marc Cruts; Jessie Theuns; Jurgen Del-Favero; Parvoneh Poorkaj; Matt Baker; Kristel Sleegers; Richard Crook; Tim De Pooter; Samira Bel Kacem; Jennifer Adamson; Dirk Van den Bossche; Marleen Van den Broeck; Jennifer Gass; Ellen Corsmit; Peter De Rijk; Natalie Thomas; Sebastiaan Engelborghs; Michael Heckman; Irene Litvan; Julia Crook; Peter P De Deyn; Dennis Dickson; Gerard D Schellenberg; Christine Van Broeckhoven; Michael L Hutton
Journal:  Hum Mol Genet       Date:  2005-09-29       Impact factor: 6.150

9.  Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.

Authors:  Matthew J Winton; Sonali Joyce; Victoria Zhukareva; Domenico Practico; Daniel P Perl; Douglas Galasko; Ula Craig; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2006-04-12       Impact factor: 17.088

10.  An improved recombineering approach by adding RecA to lambda Red recombination.

Authors:  Junping Wang; Mihail Sarov; Jeanette Rientjes; Jun Fu; Heike Hollak; Harald Kranz; Wei Xie; A Francis Stewart; Youming Zhang
Journal:  Mol Biotechnol       Date:  2006-01       Impact factor: 2.695

View more
  78 in total

1.  Human embryonic stem cell-derived neurons as a tool for studying neuroprotection and neurodegeneration.

Authors:  Giles E Hardingham; Rickie Patani; Paul Baxter; David J Wyllie; Siddharthan Chandran
Journal:  Mol Neurobiol       Date:  2010-04-30       Impact factor: 5.590

2.  Acetylation of tau inhibits its degradation and contributes to tauopathy.

Authors:  Sang-Won Min; Seo-Hyun Cho; Yungui Zhou; Sebastian Schroeder; Vahram Haroutunian; William W Seeley; Eric J Huang; Yong Shen; Eliezer Masliah; Chandrani Mukherjee; David Meyers; Philip A Cole; Melanie Ott; Li Gan
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

3.  Truncation of tau at E391 promotes early pathologic changes in transgenic mice.

Authors:  Pamela J McMillan; Brian C Kraemer; Linda Robinson; James B Leverenz; Murray Raskind; Gerard Schellenberg
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

4.  A liquid chromatography tandem mass spectroscopy approach for quantification of protein methylation stoichiometry.

Authors:  Grace L Cooper; Carol J Huseby; Claire N Chandler; Jean-Christophe Cocuron; Ana P Alonso; Jeff Kuret
Journal:  Anal Biochem       Date:  2018-03-15       Impact factor: 3.365

5.  Tau isoform expression and phosphorylation in marmoset brains.

Authors:  Govinda Sharma; Anni Huo; Taeko Kimura; Seiji Shiozawa; Reona Kobayashi; Naruhiko Sahara; Minaka Ishibashi; Shinsuke Ishigaki; Taro Saito; Kanae Ando; Shigeo Murayama; Masato Hasegawa; Gen Sobue; Hideyuki Okano; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 6.  Evolution of neurodegeneration.

Authors:  Mark R Cookson
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

7.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

9.  Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Authors:  C Vergara; L Ordóñez-Gutiérrez; F Wandosell; I Ferrer; J A del Río; R Gavín
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

10.  Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neurons.

Authors:  Pier Paolo Peruzzi; Sean E Lawler; Steve L Senior; Nina Dmitrieva; Pauline A H Edser; Davide Gianni; E Antonio Chiocca; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.